| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |